Join us today for the May session of CDC’s Public Health Grand Rounds, “Pre-Exposure Prophylaxis (PrEP) for Prevention of HIV Infection.” This session will be available via live webcast from CDC headquarters in Atlanta, Georgia on Tuesday, May 20, at 1 p.m. (EDT) at http://www.cdc.gov/cdcgrandrounds/. The webcast link is only active during the date and time of the session, but all sessions are archived for future viewing.
Each year, an estimated 50,000 individuals become infected with the human immunodeficiency virus (HIV) in the United States. A new prevention strategy, Pre-exposure Prophylaxis (PrEP), is intended for high-risk populations to reduce their risk of becoming infected with HIV. PrEP includes daily medication and routine follow-up. When used consistently, PrEP is shown to reduce the risk of HIV infection. If delivered effectively and used in combination with other proven prevention methods, PrEP may help address the HIV epidemic in the United States.
Please join us as we explore the opportunities for using PrEP as another tool to prevent the transmission of HIV and discuss the challenges to effective implementation that must be addressed.